Joff Wild Indonesia has indicated that it will be implementing a wide-ranging compulsory licensing regime relating to a number of HIV and AIDs treatments. According to reports coming out of the country, the government there has stated that the new orders will cover a range of secondary anti-retroviral treatments such as tenofovir, emtricitabine, and...

Want to read more?

Register to access two of our subscriber-only articles per month

Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts

Already registered? Log in

What our customers are saying

Well-written, in-depth coverage that is not found on this side of the ‘pond’. Thank you for that.

Frederic M Wilf
Technology, intellectual property and business lawyer
Wilftek LLC


Subscribe to receive access to the full range of premium business intelligence, insights and analysis, as well as our IP directories, guides and daily news.

Why subscribe?